Cu-MOF-based targeted nanomedicine utilizing biorthogonally catalyzed chemotherapy and chemodynamic therapy with spatiotemporal orchestration to treat hepatocellular carcinoma

A targeted nanomedicine based on a Cu-MOF was developed to treat hepatocellular carcinoma utilizing biorthogonally catalyzed chemotherapy and chemodynamic therapy, which significantly suppresses tumor growth with minimum toxicity.